1 / 11

Women’s Questionnaire TETANUS TOXOID MODULE

Women’s Questionnaire TETANUS TOXOID MODULE. Goals and Targets. MDG 5: Reduce by three quarters the maternal mortality ratio Strategy: Elimination of maternal and neonatal tetanus

dahlia
Télécharger la présentation

Women’s Questionnaire TETANUS TOXOID MODULE

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Women’s QuestionnaireTETANUS TOXOID MODULE

  2. Goals and Targets MDG 5: Reduce by three quarters the maternal mortality ratio Strategy: Elimination of maternal and neonatal tetanus Target: Reduce incidence of neonatal tetanus to less than 1 case of neonatal tetanus per 1000 live births in every district

  3. Neonatal TetanusDefinition • Caused by tetanus spores, a bacteria found everywhere in the environment • Transmission occurs when there is contact with broken skin such as an infant’s umbilical cord • Poverty, poor hygiene and limited access to health services increase the risk for transmission during childbirth

  4. Neonatal TetanusPrevention 1. Immunization of pregnant women with at least 2 doses of tetanus toxoid vaccine (TT2+), passing protection to the newborn for up to first two months of life 2. Immunization of women of childbearing age who live in areas of high risk for transmission (delivery of immunizations usually through campaigns) 3. Promotion of clean delivery and cord care practices

  5. Estimated Deaths from Vaccine Preventable Diseases

  6. Situation of Maternal and Neonatal Tetanus(Remains a problem in 51 countries) Neonatal Tetanus death reduction 248,000 200,000 180,000 MNT not eliminated Countries with TT campigns MNT eliminated * includes Timor-Leste Note: The boundaries and the names shown and the designations used on these maps do not imply official endorsement or acceptance by the United Nations.

  7. Preparation • Obtain country specific women’s immunization card(s) for easy recognition • Obtain the most recent national immunization schedule for women • Find out if any tetanus toxoid campaigns were carried out in previous year (identify month)

  8. Women’s QuestionnaireTETANUS TOXOID MODULE Purpose and Eligibility Obtain information on tetanus toxoid immunizations among women with a live birth in the previous 2 years (allows estimation of indicator based on births during the last year).

  9. Indicator

  10. Appropriate interval • two TT doses during the pregnancy (TT3>=2) • one TT dose during the pregnancy and at least one TT dose prior to the pregnancy (TT3=1 AND TT6>=1) • at least two TT doses prior to the pregnancy of which the last dose was less than 3 years before the birth • with 3 doses within the 5 years before the pregnancy • with 4 doses with the last dose less than 10 years before the pregnancy • with 5 doses or more ever (TT6>=5).

  11. TT Module • Ask to see card (TT1) • TT during last pregnancy, how many times (TT2, TT3) • Filter out for women with more than 2 doses during last pregnancy (TT4) • TT injections before last pregnancy, timing of last injection if any (TT5-TT8)

More Related